Experienced in Hepatitis E

Ping Q. Fu

Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Chengdu, CN 
Experienced in Hepatitis E
Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Ping Fu practices in Chengdu, China. Fu is rated as an Experienced expert by MediFind in the treatment of Hepatitis E. Their top areas of expertise are Rhabdomyolysis, Hyperglycerolemia, Wilson Disease, Angioplasty, and Liver Embolization.

Their clinical research consists of co-authoring 464 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Hepatitis E.

Locations

Chinese Academy Of Medical Sciences & Peking Union Medical College, Chengdu, 610052, China
Other Locations
State Key Laboratory Of Kidney Diseases, Beijing, China
152 Luoyu Avenue, Wuhan, 430079, China
No. 37, Guoxue Alley, 610041, Chengdu, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Enrollment Status: Completed
Publish Date: September 23, 2021
Intervention Type: Drug
Study Phase: Not Applicable
Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial
Efficacy and Safety of Preimplantation Genetic Diagnosis in Blocking Pathogenic Gene Inheritance for Autosomal Dominant Polycystic Kidney Disease: a Multicenter Clinical Trial
Enrollment Status: Completed
Publish Date: January 26, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
View 2 Less Clinical Trials

464 Total Publications

Efficacy and safety of haemadsorption combined with continuous renal replacement therapy for rhabdomyolysis and acute kidney injury: a single-center, open-label, randomised controlled trial protocol.
Efficacy and safety of haemadsorption combined with continuous renal replacement therapy for rhabdomyolysis and acute kidney injury: a single-center, open-label, randomised controlled trial protocol.
Journal: BMJ open
Published: November 27, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fu's expertise for a condition
ConditionClose
    View All 58 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile